Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 18, 2023

BUY
$18.22 - $25.85 $140,366 - $199,148
7,704 Added 17.97%
50,569 $971,000
Q2 2023

Jul 20, 2023

BUY
$22.62 - $39.32 $141,420 - $245,828
6,252 Added 17.08%
42,865 $1.09 Million
Q1 2023

Apr 12, 2023

BUY
$30.17 - $41.11 $136,096 - $185,447
4,511 Added 14.05%
36,613 $1.32 Million
Q4 2022

Jan 17, 2023

BUY
$36.43 - $49.4 $34,098 - $46,238
936 Added 3.0%
32,102 $1.27 Million
Q3 2022

Oct 07, 2022

SELL
$40.66 - $53.03 $13,377 - $17,446
-329 Reduced 1.04%
31,166 $1.45 Million
Q2 2022

Jul 20, 2022

BUY
$40.85 - $77.67 $187,950 - $357,359
4,601 Added 17.11%
31,495 $1.38 Million
Q1 2022

Apr 26, 2022

SELL
$59.95 - $92.06 $37,828 - $58,089
-631 Reduced 2.29%
26,894 $1.95 Million
Q4 2021

Jan 13, 2022

BUY
$81.07 - $121.29 $272,638 - $407,898
3,363 Added 13.92%
27,525 $2.23 Million
Q3 2021

Oct 18, 2021

BUY
$101.99 - $166.36 $604,902 - $986,681
5,931 Added 32.53%
24,162 $2.81 Million
Q2 2021

Jul 30, 2021

BUY
$141.6 - $179.06 $257,287 - $325,352
1,817 Added 11.07%
18,231 $3.02 Million
Q1 2021

Apr 20, 2021

BUY
$132.81 - $182.18 $973,762 - $1.34 Million
7,332 Added 80.73%
16,414 $2.29 Million
Q4 2020

Jan 19, 2021

BUY
$138.17 - $184.34 $683,803 - $912,298
4,949 Added 119.74%
9,082 $1.57 Million
Q3 2020

Oct 30, 2020

BUY
$114.09 - $145.51 $187,335 - $238,927
1,642 Added 65.92%
4,133 $576,000
Q2 2020

Jul 15, 2020

BUY
$89.45 - $129.85 $128,897 - $187,113
1,441 Added 137.24%
2,491 $298,000
Q1 2020

Apr 14, 2020

BUY
$70.23 - $144.31 $24,159 - $49,642
344 Added 48.73%
1,050 $105,000
Q4 2019

Jan 22, 2020

BUY
$76.41 - $117.54 $53,945 - $82,983
706 New
706 $83,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $116M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.